REVIVA PHARMACEUTICALS HOLDI (RVPH) Stock Cash Flow
NASDAQ:RVPH - Nasdaq - US76152G1004 - Common Stock
| TTM (2024-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-2-29) | 2019 (2019-2-28) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -33.38M | -24.34M | -8.52M | 620.00K | 570.00K | |||
| Depreciation Amortization | N/A | N/A | 0.00 | 0.00 | N/A | |||
| Change In Working Capital | -607.34K | 5.01M | -700.00K | 300.00K | -70.00K | |||
| Interest Paid | 24.00K | N/A | 0.00 | 330.00K | N/A | |||
| Taxes Paid | 4.50K | 20.00K | 0.00 | 0.00 | N/A | |||
| Other non cash items | 671.19K | 370.00K | -1.44M | -1.34M | -730.00K | |||
| OPERATING CASH FLOW | -33.32M | -18.96M | -10.67M | -430.00K | -220.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | N/A | N/A | N/A | 5.70M | -64.52M | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | 5.70M | -64.52M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -139.50K | N/A | N/A | 750.00K | N/A | |||
| Stock Issued/Repurchased | N/A | 7.79M | 31.60M | -6.27M | 65.44M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 0.00 | -390.00K | |||
| FINANCING CASH FLOW | 33.91M | 7.79M | 31.60M | -5.52M | 65.05M | |||
| CHANGE IN CASH | 586.52K | -11.17M | 20.93M | -250.00K | 310.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -33.32M | -18.96M | -10.67M | -430.00K | -220.00K | |||
| FREE CASH FLOW | -33.32M | -18.96M | -10.67M | -430.00K | -220.00K | |||
All data in USD